Targeted Serum Metabolite Profiling Identifies Metabolic Signatures in Patients with Alzheimer's Disease, Normal Pressure Hydrocephalus and Brain Tumor
Progression to AD is preceded by elevated levels of 2,4-dihydroxybutanoic acid (2,4-DHB), implicating hypoxia in early pathogenesis. Since hypoxia may play a role in multiple CNS disorders, we investigated serum metabolite profiles across three disorders, AD, Normal Pressure Hydrocephalus (NPH) and...
Main Authors: | Matej Orešič, Gabriella Anderson, Ismo Mattila, Manoucher Manoucheri, Hilkka Soininen, Tuulia Hyötyläinen, Cherlynn Basignani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnins.2017.00747/full |
Similar Items
-
Metabolic Signatures of the Exposome—Quantifying the Impact of Exposure to Environmental Chemicals on Human Health
by: Matej Orešič, et al.
Published: (2020-11-01) -
Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients
by: Linda Ahonen, et al.
Published: (2019-09-01) -
The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic mice.
by: Thomas U Greiner, et al.
Published: (2014-01-01) -
Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations
by: Santosh Lamichhane, et al.
Published: (2021-01-01) -
Integrative Analysis of Circulating Metabolite Profiles and Magnetic Resonance Imaging Metrics in Patients with Traumatic Brain Injury
by: Ilias Thomas, et al.
Published: (2020-02-01)